Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 2 | 2019 | 454 | 0.820 |
Why?
|
| Mutation | 5 | 2019 | 6058 | 0.710 |
Why?
|
| Pericarditis | 1 | 2020 | 42 | 0.630 |
Why?
|
| Myocarditis | 1 | 2021 | 122 | 0.630 |
Why?
|
| Pericardial Effusion | 1 | 2020 | 75 | 0.620 |
Why?
|
| Capillaries | 1 | 2019 | 63 | 0.600 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 105 | 0.590 |
Why?
|
| Hemangioma | 1 | 2019 | 86 | 0.560 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2018 | 15 | 0.560 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2018 | 362 | 0.450 |
Why?
|
| Consanguinity | 1 | 2015 | 115 | 0.430 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 434 | 0.430 |
Why?
|
| Lung | 1 | 2019 | 1531 | 0.350 |
Why?
|
| Heart Failure | 3 | 2020 | 2325 | 0.350 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 555 | 0.350 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2022 | 61 | 0.350 |
Why?
|
| Lebanon | 4 | 2019 | 10 | 0.320 |
Why?
|
| Pedigree | 4 | 2020 | 1668 | 0.260 |
Why?
|
| Surgical Procedures, Operative | 2 | 2020 | 225 | 0.250 |
Why?
|
| Stroke Volume | 2 | 2019 | 540 | 0.240 |
Why?
|
| Transcription Factors | 1 | 2015 | 2402 | 0.220 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 736 | 0.220 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 1875 | 0.190 |
Why?
|
| Technetium | 1 | 2022 | 13 | 0.190 |
Why?
|
| Prognosis | 3 | 2021 | 4866 | 0.180 |
Why?
|
| Health Status Indicators | 1 | 2020 | 111 | 0.150 |
Why?
|
| Pericardium | 1 | 2020 | 103 | 0.150 |
Why?
|
| Troponin I | 1 | 2020 | 121 | 0.150 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2021 | 178 | 0.150 |
Why?
|
| RNA, Viral | 1 | 2021 | 498 | 0.150 |
Why?
|
| Middle Aged | 8 | 2022 | 28420 | 0.150 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2022 | 227 | 0.140 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2019 | 88 | 0.140 |
Why?
|
| Humans | 17 | 2022 | 130511 | 0.140 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2020 | 161 | 0.140 |
Why?
|
| Electric Impedance | 1 | 2018 | 71 | 0.140 |
Why?
|
| Aortic Valve Stenosis | 1 | 2022 | 349 | 0.140 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2022 | 298 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 229 | 0.130 |
Why?
|
| Xanthomatosis | 1 | 2017 | 8 | 0.130 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 245 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2021 | 520 | 0.130 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2017 | 30 | 0.130 |
Why?
|
| Phytosterols | 1 | 2017 | 28 | 0.130 |
Why?
|
| Echocardiography | 2 | 2020 | 1124 | 0.130 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 67 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2019 | 356 | 0.120 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 2111 | 0.120 |
Why?
|
| Incidence | 2 | 2021 | 3336 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 567 | 0.120 |
Why?
|
| Skin Diseases | 1 | 2017 | 141 | 0.120 |
Why?
|
| Male | 11 | 2022 | 64586 | 0.110 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 548 | 0.110 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2015 | 20 | 0.110 |
Why?
|
| Hypercholesterolemia | 1 | 2017 | 230 | 0.110 |
Why?
|
| Pemphigus, Benign Familial | 1 | 2015 | 11 | 0.110 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2015 | 37 | 0.110 |
Why?
|
| Heat-Shock Response | 1 | 2015 | 33 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 482 | 0.110 |
Why?
|
| Penetrance | 1 | 2015 | 107 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 514 | 0.110 |
Why?
|
| Young Adult | 3 | 2020 | 10033 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 6772 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2022 | 1161 | 0.100 |
Why?
|
| Genetic Linkage | 1 | 2015 | 461 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 998 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1069 | 0.090 |
Why?
|
| Stroke | 1 | 2020 | 1059 | 0.090 |
Why?
|
| Female | 10 | 2022 | 70545 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 817 | 0.080 |
Why?
|
| Aged | 5 | 2022 | 20897 | 0.080 |
Why?
|
| Adult | 5 | 2020 | 31115 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2020 | 6424 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2015 | 848 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2018 | 15028 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 2298 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2019 | 5048 | 0.080 |
Why?
|
| Phenotype | 2 | 2020 | 4455 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 664 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2015 | 969 | 0.070 |
Why?
|
| Genotype | 1 | 2015 | 2589 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 5185 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3751 | 0.070 |
Why?
|
| Child | 3 | 2020 | 26233 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2015 | 1554 | 0.070 |
Why?
|
| Prevalence | 1 | 2015 | 2693 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3422 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3124 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2897 | 0.050 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 2022 | 1 | 0.050 |
Why?
|
| Diphosphates | 1 | 2022 | 8 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2022 | 113 | 0.050 |
Why?
|
| Infant | 1 | 2018 | 13293 | 0.050 |
Why?
|
| Tricuspid Valve | 1 | 2022 | 58 | 0.050 |
Why?
|
| Adolescent | 2 | 2020 | 20876 | 0.040 |
Why?
|
| Founder Effect | 1 | 2020 | 32 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 41 | 0.040 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2020 | 83 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2020 | 3687 | 0.040 |
Why?
|
| North America | 1 | 2020 | 255 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 252 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2022 | 17650 | 0.040 |
Why?
|
| Heart Atria | 1 | 2021 | 341 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2022 | 810 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2020 | 268 | 0.030 |
Why?
|
| Tunisia | 1 | 2017 | 5 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2020 | 1613 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 533 | 0.030 |
Why?
|
| Myocardium | 1 | 2020 | 846 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2022 | 12851 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 1589 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 1262 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1234 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 11011 | 0.030 |
Why?
|
| Heterozygote | 1 | 2017 | 721 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1874 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2019 | 715 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 1481 | 0.020 |
Why?
|
| Family | 1 | 2015 | 587 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3365 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6169 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2882 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 3368 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 33725 | 0.010 |
Why?
|